Distinct fibronectin splicing variants: Potential targets for therapeutic immunomodulation in organ allograft recipients

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 1060-1061

  Coito, A J ^a   Korom, S ^a   Van De Water, L ^b   Kupiec Weglinski, J W ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; SYNTHETIC PEPTIDE;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ALTERNATIVE SPLICING; ANIMALS; FIBRONECTINS; HEART TRANSPLANTATION; IMMUNOSUPPRESSION; INTEGRIN ALPHA4BETA1; INTEGRINS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RATS, INBRED STRAINS; RECEPTORS, LYMPHOCYTE HOMING; RECEPTORS, VERY LATE ANTIGEN; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VARIATION (GENETICS);

EID: 0030946678     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00382-X     Document Type: Conference Paper

References (1)

1. Coito AJ, Binder J, de Sousa M, et al: Transplantation 57:599, 1994